SULLIVAN LOUIS W
SEC CIK 1193522 · EDGAR
BoughtSold
Most active insiders at UTHR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROTHBLATT MARTINE A | COB, CEO, Dir | -$863.9K | $840.04M |
| 2 | BENKOWITZ MICHAEL | Pres AND COO | — | $226.97M |
| 3 | EDGEMOND JAMES | CFO AND Treas | — | $211.57M |
| 4 | MAHON PAUL A | EVP, GC | — | $114.08M |
| 5 | SULLIVAN LOUIS W | Dir | — | $3.05M |
| 6 | PATUSKY CHRISTOPHER | Dir | — | $2.73M |
| 7 | Thompson Tommy G | Dir | — | $2.51M |
| 8 | KURZWEIL RAY | Dir | — | $2.40M |
| 9 | CAUSEY CHRISTOPHER | Dir | — | $2.33M |
| 10 | Olian Judy D. | Dir | — | $417.0K |
Transactions 32
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-13 16:34 | 2026-07-09 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | M - OptEx | $0.00 | +650 | 2,983 | +28% | $0 |
| DMI | 2025-12-23 | 2025-12-22 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | M - OptEx | $204.93 | +5,950 | 3,230 | New | +$1.22M |
| DMI | 2025-12-23 | 2025-12-22 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | S - Sale+OE | $512.14 | -5,950 | 4,863 | -55% | -$3.05M |
| DI | 2025-07-28 | 2025-07-25 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | M - OptEx | $0.00 | +590 | 590 | New | $0 |
| D | 2025-05-02 | 2025-04-30 | EBS | Emergent BioSolutions Inc. | SULLIVAN LOUIS W | Dir | A - Grant | $0.00 | +34.4K | 139.1K | +33% | $0 |
| DM | 2024-12-19 | 2024-12-18 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | S - Sale+OE | $373.22 | -26.2K | 12.0K | -69% | -$9.78M |
| D | 2024-12-19 | 2024-12-18 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | M - OptEx | $175.43 | +15.0K | 31.3K | +92% | +$2.63M |
| D | 2024-12-19 | 2024-12-19 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | G - Gift | $0.00 | -1,851 | 3,200 | -37% | $0 |
| D | 2024-05-28 | 2024-05-23 | EBS | Emergent BioSolutions Inc. | SULLIVAN LOUIS W | Dir | A - Grant | $0.00 | +17.4K | 104.7K | +20% | $0 |
| DM | 2024-05-06 | 2024-05-03 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | S - Sale+OE | $258.39 | -5,160 | 16.0K | -24% | -$1.33M |
| D | 2024-05-06 | 2024-05-03 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | M - OptEx | $119.76 | +5,160 | 18.2K | +40% | +$618.0K |
| D | 2023-07-07 | 2023-07-07 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | M - OptEx | $0.00 | +880 | 13.1K | +7% | $0 |
| 2023-05-30 | 2023-05-25 | EBS | Emergent BioSolutions Inc. | SULLIVAN LOUIS W | Dir | A - Grant | $0.00 | +33.8K | 87.3K | +63% | $0 | |
| D | 2023-03-02 | 2023-03-01 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | M - OptEx | $132.30 | +700 | 12.9K | +6% | +$92.6K |
| D | 2023-03-02 | 2023-03-01 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | S - Sale+OE | $245.10 | -700 | 12.2K | -5% | -$171.6K |
| D | 2023-02-02 | 2023-02-01 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | M - OptEx | $132.30 | +700 | 12.9K | +6% | +$92.6K |
| D | 2023-02-02 | 2023-02-01 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | S - Sale+OE | $261.33 | -700 | 12.2K | -5% | -$182.9K |
| D | 2023-01-03 | 2023-01-03 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | S - Sale+OE | $276.26 | -700 | 12.2K | -5% | -$193.4K |
| D | 2023-01-03 | 2023-01-03 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | M - OptEx | $132.30 | -700 | 12.9K | -5% | -$92.6K |
| D | 2022-12-01 | 2022-12-01 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | S - Sale+OE | $279.89 | -700 | 12.2K | -5% | -$195.9K |
| D | 2022-12-01 | 2022-12-01 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | M - OptEx | $132.30 | +700 | 12.9K | +6% | +$92.6K |
| D | 2022-11-02 | 2022-11-01 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | S - Sale+OE | $230.28 | -700 | 12.2K | -5% | -$161.2K |
| D | 2022-11-02 | 2022-11-01 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | M - OptEx | $132.30 | +700 | 12.9K | +6% | +$92.6K |
| D | 2022-10-03 | 2022-10-03 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | M - OptEx | $132.30 | +710 | 12.9K | +6% | +$93.9K |
| D | 2022-10-03 | 2022-10-03 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | S - Sale+OE | $211.56 | -710 | 12.2K | -6% | -$150.2K |
| D | 2022-09-06 | 2022-09-02 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | S - Sale+OE | $225.98 | -4,910 | 12.2K | -29% | -$1.11M |
| D | 2022-09-06 | 2022-09-02 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | M - OptEx | $101.80 | +4,910 | 17.1K | +40% | +$499.8K |
| DA | 2022-07-11 | 2022-07-08 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | M - OptEx | $0.00 | +1,080 | 12.2K | +10% | $0 |
| D | 2022-07-08 | 2022-07-08 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | M - OptEx | $0.00 | +3,230 | 14.3K | +29% | $0 |
| 2022-05-31 | 2022-05-26 | EBS | Emergent BioSolutions Inc. | SULLIVAN LOUIS W | Dir | A - Grant | $0.00 | +8,446 | 53.4K | +19% | $0 | |
| DM | 2022-05-26 | 2022-05-26 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | S - Sale+OE | $225.01 | -6,310 | 12.4K | -34% | -$1.42M |
| D | 2022-05-26 | 2022-05-26 | UTHR | UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W | Dir | M - OptEx | $76.36 | +6,310 | 17.4K | +57% | +$481.8K |
Purchase Sale Sale after option exercise All abbreviations